Gene · 6391
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic addition of m5C to HBV transcripts promotes viral replication and evasion of innate antiviral responses. | Cell Death Dis | 2024 | 38216565 | PubTator, text mining | PubMed |
| Prothymosin α accelerates dengue virus-induced thrombocytopenia. | iScience | 2024 | 38213625 | PubTator, text mining | PubMed |
| Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners. | Nat Commun | 2024 | 38212624 | PubTator, text mining | PubMed |
| Association of abnormal NDUFB2 and UQCRH expression with venous thromboembolism in patients with liver cirrhosis. | Medicine (Baltimore) | 2024 | 38181234 | PubTator, text mining | PubMed |
| Vitamin D binding protein (VDBP) hijacks twist1 to inhibit vasculogenic mimicry in hepatocellular carcinoma. | Theranostics | 2024 | 38164156 | PubTator, text mining | PubMed |
| Complex II ambiguities-FADH2 in the electron transfer system. | J Biol Chem | 2024 | 38118236 | PubTator, text mining | PubMed |
| SMYD3 activates the TCA cycle to promote M1-M2 conversion in macrophages. | Int Immunopharmacol | 2024 | 38091832 | PubTator, text mining | PubMed |
| IGF2BP2 Drives Cell Cycle Progression in Triple-Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A-Modified CDK6 Translation Initiation Process. | Adv Sci (Weinh) | 2024 | 37983610 | PubTator, text mining | PubMed |
| Hereditary succinate dehydrogenase-deficient renal cell carcinoma. | Semin Diagn Pathol | 2024 | 37981479 | PubTator, text mining | PubMed |
| Th17 cells target the metabolic miR-142-5p-succinate dehydrogenase subunit C/D (SDHC/SDHD) axis, promoting invasiveness and progression of cervical cancers. | Mol Oncol | 2024 | 37899663 | PubTator, text mining | PubMed |
| SP4 Facilitates Esophageal Squamous Cell Carcinoma Progression by Activating PHF14 Transcription and Wnt/Β-Catenin Signaling. | Mol Cancer Res | 2024 | 37768180 | PubTator, text mining | PubMed |
| Zinc finger protein 831 promotes apoptosis and enhances chemosensitivity in breast cancer by acting as a novel transcriptional repressor targeting the STAT3/Bcl2 signaling pathway. | Genes Dis | 2024 | 37588209 | PubTator, text mining | PubMed |
| KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study. | Oncologist | 2024 | 37463014 | PubTator, text mining | PubMed |
| Sequence-Dependent Material Properties of Biomolecular Codensates and their Relation to Dilute Phase Conformations. | bioRxiv | 2024 | 37215004 | PubTator, text mining | PubMed |
| Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia. | Front Oncol | 2023 | 38260858 | PubTator, text mining | PubMed |
| A Case of Von Hippel-Lindau Disease With Recurrence of Paraganglioma and No Other Associated Symptoms: The Importance of Genetic Testing and Establishing Follow-Up Policies. | Cureus | 2023 | 38222164 | PubTator, text mining | PubMed |
| In Vitro Circadian Clock Gene Expression Assessments in Mesenchymal Stem Cells from Human Infants: A Pilot Study. | Nutrients | 2023 | 38201882 | PubTator, text mining | PubMed |
| Modulation of neural gene networks by estradiol in old rhesus macaque females. | bioRxiv | 2023 | 38187564 | PubTator, text mining | PubMed |
| Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas. | Front Endocrinol (Lausanne) | 2023 | 38155946 | PubTator, text mining | PubMed |
| An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma. | Front Endocrinol (Lausanne) | 2023 | 38152133 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6391/papers?page=8